Effect of Social Media Support and Financial Incentives on PrEP Adherence
NCT ID: NCT03078153
Last Updated: 2021-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2017-04-01
2020-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicomponent Intervention to Increase HIV Risk Perceptions and PrEP Initiation Among Black Men Who Have Sex With Men
NCT04533386
SNS and PrEP Initiation and Adherence in Black SMM
NCT05499962
Optimizing PrEP Adherence for Young Men Who Have Sex With Men
NCT03493555
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
NCT01808352
Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media
NCT03404531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Financial Incentive
Provided financial incentive at 3-month and 6-month follow-up visits
Financial Incentive
Participants will receive a $50 gift card at 3- and 6- month follow-up visits.
Social Media Group
Provided social media support through a facebook group for 6 months
Social Media Group
Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP
Control
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Financial Incentive
Participants will receive a $50 gift card at 3- and 6- month follow-up visits.
Social Media Group
Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-24
* Black/African American, Latino or Asian
* HIV negative
* History of unprotected anal sex with a man in the last 6 months
* Living within the DC metropolitan statistical area and anticipate remaining within the DC area for the next 6 months
* Not enrolled in any other HIV prevention trial
* Interested in taking PrEP
* Not a current PrEP user and have not taken PrEP in the last 30 days
* Able to provide informed consent
Exclusion Criteria
* Age younger than 18 or older than 24
* Caucasian
* HIV positive
* Actively taking PrEP or having taken PrEP within 30 days of enrollment
* Chronic hepatitis B infection
* Known renal insufficiency
* On probation or parole
* Any other conditions that the Principal Investigator may consider a contraindication to enrolling in the study
18 Years
24 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Gilead Sciences
INDUSTRY
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marc O. Siegel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Siegel, MD
Role: PRINCIPAL_INVESTIGATOR
The GW Medical Faculty Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The GW Medical Faculty Associates
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111642
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.